PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

20th Annual National Jewish Health Respiratory Disease Young Investigators’ Forum calls for abstracts

2024-02-17
(Press-News.org) DENVER — Young physician investigators interested in research careers in pulmonology, allergy and immunology, pediatric and related programs, are encouraged to submit basic science or clinical research abstracts by June 3, 2024, to be considered for participation in the 20th Annual Respiratory Disease Young Investigators’ Forum. This year’s Forum will take place October 17-20, 2024, in Denver.

The annual event provides career development and research opportunities for fellows and early career faculty. The Forum is a celebration of talent and ingenuity in respiratory medicine. Physician-scientists in fellowship and early career stages are encouraged to submit their abstracts to be considered for this opportunity to showcase their research, connect with industry leaders, and contribute to the advancement of respiratory disease research.

"The Young Investigators’ Forum has been a catalyst for groundbreaking discoveries, and we are thrilled to celebrate its 20th anniversary this year. We invite physician scientists from around the country to submit research abstracts for the opportunity to join us as we continue to shape the future of respiratory medicine together," said Jeff Swigris, DO, pulmonologist at National Jewish Health and last year’s program chair.

This unique educational opportunity is designed for pulmonary, allergy and immunology fellows and junior faculty who are in their first few years in an academic role. Thirty investigators, whose Basic Science Research or Clinical Research abstracts are selected, will be invited to present their research at the Forum in the fall, where a panel of expert faculty will evaluate their presentations and score them on specified criteria. Selected winners will receive a monetary award to support their future research endeavors in respiratory medicine. Throughout the Forum, attendees will enjoy opportunities to meet and interact with expert faculty and peer researchers.

At last year’s Forum, 29 early career physician-scientists were selected to present research in one of two categories: Basic Science or Clinical Research. The top three winners in each category received awards as well as a monetary prize to support their future research.

The top 3 winners in the 2023 Basic Science and Clinical Research Categories were:

1st Place Basic Science: Eno-Obong Essien, MD, University of Pennsylvania Hospital: Nanoparticles for Lung Disease: Risks, Challenges, and Solutions

1st Place Clinical Research: Agnes S. Montgomery, MD, Children's National Hospital: Prematurity and Obstructive Sleep Apnea Risk in Early Childhood: The Role of Early‐Life Lower Respiratory Tract Infections

2nd Place Basic Science: Daniel Colon Hidalgo, MD, University of Colorado: Genetic Variant of EC‐SOD Leads to Worsened Pulmonary Hypertension Severity Due to Alterations in Mitochondrial Function

2nd Place Clinical Research: Jonathan Rose, MD, Brigham and Women's Hospital: Genetic Variant of EC‐SOD Leads to Worsened Pulmonary Hypertension Severity Due to Alterations in Mitochondrial Function

3rd Place Basic Science: Matthew McCarra, MD, Stanford University: TERT Expressing Alveolar Type II Cells As Unipotent Progenitors of the Distal Lung

3rd Place Clinical Research: Kristin Berger, MD, New York-Presbyterian/Weill Cornell Medical Center: Airway Tree Caliber and Subclinical Interstitial Lung Disease in Community‐Dwelling Adults: The Multi‐Ethnic Study of Atherosclerosis (MESA)

For more information about the 2024 20th Annual Young Investigator's Forum and to apply, please visit njhealth.org/YIF2024.

National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

END


ELSE PRESS RELEASES FROM THIS DATE:

Study highlights importance of genetic sequencing to diagnosis of growth disorders

2024-02-16
In an article published in the Journal of Pediatrics, researchers based in Brazil describe the case of a nine-year-old boy admitted to hospital with multiple symptoms and overlapping conditions that made diagnosis difficult, such as short stature, thin tooth enamel (dental enamel hypoplasia), moderate mental deficiency, speech delay, asthma, mildly altered blood sugar, and a history of recurring infections in infancy.  The team used exome sequencing, in which only the protein-coding portion of the genome is analyzed, to look for genetic mutations, and found them in GCK and BCL11B. ...

Sylvester appoints prominent oncologist-researcher to lead transplantation and cellular therapy

Sylvester appoints prominent oncologist-researcher to lead transplantation and cellular therapy
2024-02-16
MIAMI, FLORIDA (Feb. 15, 2024) – Prominent oncologist and researcher Damian Green, M.D., will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Green will serve as chief of Sylvester’s Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1. He joins Sylvester from Fred Hutchinson Cancer Center in Seattle, where he built a distinguished track record in research and ...

Without social distancing, how do bacteria survive a viral epidemic?

Without social distancing, how do bacteria survive a viral epidemic?
2024-02-16
By Wynne Parry WOODS HOLE, Mass. – Like humans struggling to get through the COVID-19 pandemic, bacterial cells need social distancing to thwart viruses. But in some situations, such as inside elevators or within the candy-colored bacterial structures known as “pink berries,” staying apart just isn’t feasible. Looking like spilled Nerds or Pop Rocks, the communal, multicellular pink berries  litter the submerged surface of salt marshes in and around Woods Hole. New research conducted at the Marine Biological ...

Commercial AI tool moderately successful at predicting hospitalization-related kidney injury

2024-02-16
Hospital-acquired acute kidney injury (HA-AKI) is a common complication in hospitalized patients that can lead to chronic kidney disease and is associated with longer hospital stays, higher health care costs and increased mortality. Given these negative consequences, preventing HA-AKI can improve hospitalized patient outcomes. However, anticipating HA-AKI onset is difficult due to a large number of contributing factors involved. Researchers from Mass General Brigham Digital tested a commercial machine learning tool, the Epic Risk of HA-AKI predictive model, and found it was moderately successful at predicting risk of HA-AKI in recorded patient data. ...

JMIR Bioinformatics and Biotechnology has passed the Scientific Quality Review by NLM for PMC

2024-02-16
(Toronto, February 16, 2024) JMIR Publications is pleased to announce that JMIR Bioinformatics and Biotechnology has passed the Scientific Quality Review by the US National Library of Medicine (NLM) for PubMed Central (PMC). This decision reflects the scientific and editorial quality of the journal. All articles published from 2022 onward will be found on PMC and PubMed after their technical evaluation.  Launched in 2020, JMIR Bioinformatics and Biotechnology is a sister journal of Journal of Medical Internet Research ...

Modifying chemotherapy treatment can make life better for older adults with cancer

2024-02-16
Standard chemotherapy regimens, which are mostly based on testing in relatively young and healthy patients, may do more harm to older adults with cancer who often struggle with other health issues. New research, published yesterday in JAMA Network Open, shows that lowering the dose and adjusting the schedule of how chemotherapy is given to older adults with advanced cancer can make life better for patients, without compromising their treatment goals. The study, which was led by researchers from the University of Rochester Medical Center’s Wilmot Cancer Institute, focuses on how well older people tolerate chemotherapy. More than 30 percent of patients benefitted from treatment regimen ...

Widely used machine learning models reproduce dataset bias in Rice study

2024-02-16
HOUSTON – (Feb. 16, 2024) – Rice University computer science researchers have found bias in widely used machine learning tools used for immunotherapy research. Ph.D. students Anja Conev, Romanos Fasoulis and Sarah Hall-Swan, working with computer science faculty members Rodrigo Ferreira and Lydia Kavraki, reviewed publicly available peptide-HLA (pHLA) binding prediction data and found it to be skewed toward higher-income communities. Their paper examines the way that biased data input affects the algorithmic recommendations being ...

Study finds risk-reducing mastectomy (RRM) may lower breast cancer mortality

Study finds risk-reducing mastectomy (RRM) may lower breast cancer mortality
2024-02-16
A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women’s College Hospital, finds risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant, significantly reduces the risk of being diagnosed with breast cancer and lowers the probability of death. The study, published in the British Journal of Cancer, examined how RRM affects the rate of death of women with a pathogenic variant but no cancer diagnosis. To date, there has been only one other study published by researchers in the Netherlands that examines the impact ...

Hope Foundation announces Goodman for Inaugural Meyskens Lecture

2024-02-16
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, has recently established the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention. Since the early 1980’s, Dr. Meyskens has been a leader in the recognition, development, and clinical usage of Prevention in the management of cancer. Frank and Linda have directed the development of this lectureship to advance the explosion of knowledge that is expanding opportunities to engage Prevention in personalized medicine, including early detection and genetically ...

Rare case of opossum infected by rabies sounds alarm regarding circulation of this virus in urban environments

Rare case of opossum infected by rabies sounds alarm regarding circulation of this virus in urban environments
2024-02-16
A female White-eared opossum (Didelphis albiventris) found dead in 2021 in Bosque dos Jequitibás Park in the center of Campinas, one of the largest cities in São Paulo state, Brazil, died from rabies meningoencephalitis, according to a group of researchers at the University of São Paulo (USP) and Adolfo Lutz Institute (IAL), the regional reference laboratory, working with health professionals affiliated with public institutions in São Paulo city and Campinas.  Reported in an article published in the journal Emerging Infectious Diseases, the finding serves as an alert to the presence of the virus, which is deadly to humans, ...

LAST 30 PRESS RELEASES:

Sitting too long can harm heart health, even for active people

International cancer organizations present collaborative work during oncology event in China

One or many? Exploring the population groups of the largest animal on Earth

ETRI-F&U Credit Information Co., Ltd., opens a new path for AI-based professional consultation

New evidence links gut microbiome to chronic disease outcomes

Family Heart Foundation appoints Dr. Seth Baum as Chairman of the Board of Directors

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Compound metalens achieves distortion-free imaging with wide field of view

Age on the molecular level: showing changes through proteins

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

[Press-News.org] 20th Annual National Jewish Health Respiratory Disease Young Investigators’ Forum calls for abstracts